Please use this identifier to cite or link to this item:
Type: Outro documento
Title: Insulin resistance in schizophrenia
Author: Guest, Paul C.
Abstract: Schizophrenia and diabetes have been known to be linked disorders for decades. One reason is due to the fact that a major side effect of antipsychotic medication treatment is metabolic syndrome, which increases the risk of the patients developing type 2 diabetes and cardiovascular disorders. However, signs of metabolic syndrome in schizophrenia patients were identified more than 100 years ago, even before the development of antipsychotic drugs. This suggests that schizophrenia itself predisposes towards diabetes and, in turn, insulin resistance may be a risk factor for the development of schizophrenia. This review summarizes the findings surrounding this issue and places them into context with regards to increasing our understanding of the aetiology of schizophrenia and in support of biomarker and drug discovery efforts
Subject: Esquizofrenia
Resistência à insulina
Marcadores biológicos
Country: Estados Unidos
Editor: Springer
Rights: Fechado
Identifier DOI: 10.1007/978-3-030-12668-1_1
Date Issue: Mar-2019
Appears in Collections:IB - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
2-s2.0-85063953557.pdf503.65 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.